Abstract:Currently there is no reliable nomogram to predict the probabilities of having indications for adjuvant prostate radiation therapy for patients with clinically localized prostate cancer who plans radical prostatectomy (RP). The purpose of this study is to examine our cohort of RP patients and to develop the above nomogram through the correlation of pretreatment PSA, clinical T stage and biopsy Gleason Score with adverse features such as extraprostatic extension, positive margin(s), and Gleason Score 8-10 that are commonly indicated for adjuvant radiation therapy. We analyzed 1440 RP patients between August, 2000 and August, 2015 at our hospital. Patients who had a history of neoadjuvant hormonal therapy, or transurethral resection of the prostate (TURP) were excluded from this analysis. A total of 627 patients were eligible for analysis. Average age was 66 years. All patients had a preoperative PSA level, biopsy Gleason Score, pelvic MRI and clinical T stage (TNM 2009 classification). Preoperative PSA level clinical T stage (T2a/b, T2c, T3a, T3b), and biopsy Gleason score (5 to 6, 3+4 = 7, 4 + 3 = 7, 8 to 10) were recorded as preoperative predictors. These predictors were used in multivariable logistic regression analysis based nomograms to estimate the probabilities of extraprostatic extension, positive margin(s), Gleason Score 8-10 after RP, respectively. The predictive accuracy and discriminative ability of the nomogram were determined by concordance index (C-index) and calibration curve. Analyses were performed with open-source statistical software (version 3.2.1). Preoperatively, 41% of patients had a PSA level between 10 and 20 ng/mL, 80% had T2, and 50% had biopsy Gleason score 7; postoperatively, 47% had extraprostatic extension disease, 36% had positive margin, and 22% had Gleason Score 8-10. Nomograms were developed for the predicted probabilities of having the indications of adjuvant radiation therapy (pathologically extraprostatic extension disease or positive margin(s), or Gleason Score 8-10, respectively). The calibration curve for probabilities showed good agreement between prediction by nomogram and actual observation. The C-index of the nomograms for predicting for extraprostatic extension disease, or positive margin(s), or Gleason Score 8-10 were 0.707, 0.659, 0.897, respectively. The risk of having one of the indications of adjuvant radiation therapy increased with increases in predictors except for clinical T stage for predicting Gleason Score 8-10 (P = 0.25). Using clinic-pathological information, we produced nomograms which may accurately predict the probabilities of having indications for adjuvant radiation therapy after RP. This nomogram may help individualize initial treatment options.

The prognostic nomogram including MRI for locally advanced prostate cancer treated by radical prostatectomy

Prognostic Nomogram for patients undergoing radical Pancreaticoduodenectomy for adenocarcinoma of the pancreatic head

Integration of Multiparameter MRI into Conventional Pretreatment Risk Factors to Predict Positive Surgical Margins after Radical Prostatectomy.

Development of preoperative nomograms to predict the risk of overall and multifocal positive surgical margin after radical prostatectomy

Diagnostic Performance of a Nomogram Incorporating Cribriform Morphology for the Prediction of Adverse Pathology in Prostate Cancer at Radical Prostatectomy

Development and Validation of a Preoperative Nomogram for Predicting Positive Surgical Margins after Laparoscopic Radical Prostatectomy

A Reliable Nomogram is Identified to Predict the Probabilities of Having Indications for Adjuvant Prostatic Radiation Therapy

Magnetic resonance imaging‐based radiomics nomogram for the evaluation of therapeutic responses to neoadjuvant chemohormonal therapy in high‐risk non‐metastatic prostate cancer

Development and Validation of Multicenter Predictive Nomograms for Locally Advanced Pancreatic Cancer after Chemoradiotherapy

MultiParametric Magnetic Resonance Imaging-Based Nomogram for Predicting Prostate Cancer and Clinically Significant Prostate Cancer in Men Undergoing Repeat Prostate Biopsy.

Development and internal validation of a novel nomogram for predicting lymph node invasion for prostate cancer patients undergoing extended pelvic lymph node dissection

A novel nomogram provides improved accuracy for predicting biochemical recurrence after radical prostatectomy

Development and comparison of a Chinese nomogram adding multi-parametric MRI information for predicting extracapsular extension of prostate cancer.

Prediction of clinically significant prostate cancer with a multimodal MRI-based radiomics nomogram

Can a nomogram predict apical prostate cancer pathology upgrade from fusion biopsy to final pathology? A multicenter study

Development and Validation of Nomograms Based on Nutritional Risk Index for Predicting Extracapsular Extension and Seminal Vesicle Invasion in Patients Undergoing Radical Prostatectomy.

Peri-prostatic Adipose Tissue Measurements Using MRI Predict Prostate Cancer Aggressiveness in Men Undergoing Radical Prostatectomy

Pathologic-Based Nomograms for Predicting Overall Survival and Disease-Free Survival among Patients with Locally Advanced Rectal Cancer.

Prognostic Nomograms for Predicting Survival and Distant Metastases in Locally Advanced Rectal Cancers.

Establishment and validation of nomogram for positive surgical margin of prostate cancer

A Nomogram Based on Clinical Factors to Predict Locally Advanced Stage of Rectal Cancer